HealthEquity, Inc. (NASDAQ:HQY) Receives Consensus Recommendation of "Buy" from Analysts

Shares of HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) have received an average rating of "Buy" from the eleven analysts that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating on the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $118.5455.

HQY has been the subject of a number of recent analyst reports. Bank of America lifted their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the company a "buy" rating in a report on Wednesday, June 4th. JMP Securities lifted their price objective on shares of HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a report on Wednesday, June 4th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a report on Thursday, June 5th. Raymond James Financial reaffirmed a "strong-buy" rating and issued a $120.00 price objective (up previously from $115.00) on shares of HealthEquity in a report on Tuesday, July 8th. Finally, Wall Street Zen upgraded shares of HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th.

HealthEquity Stock Performance

HQY stock traded up $0.2050 during midday trading on Monday, hitting $91.2650. 137,221 shares of the stock traded hands, compared to its average volume of 1,001,406. HealthEquity has a 1-year low of $73.84 and a 1-year high of $116.65. The company has a debt-to-equity ratio of 0.50, a current ratio of 4.06 and a quick ratio of 4.06. The stock's fifty day simple moving average is $97.07 and its 200-day simple moving average is $96.80. The firm has a market cap of $7.89 billion, a P/E ratio of 67.05, a PEG ratio of 1.38 and a beta of 0.54.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. The company had revenue of $330.80 million during the quarter, compared to analysts' expectations of $322.25 million. During the same quarter in the previous year, the company earned $0.80 earnings per share. HealthEquity has set its FY 2026 guidance at 3.610-3.78 EPS. On average, analysts expect that HealthEquity will post 2.32 earnings per share for the current year.

Insider Activity

In related news, EVP Michael Henry Fiore sold 1,794 shares of the business's stock in a transaction dated Monday, July 7th. The shares were sold at an average price of $101.73, for a total transaction of $182,503.62. Following the transaction, the executive vice president directly owned 53,225 shares in the company, valued at approximately $5,414,579.25. The trade was a 3.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Jon Kessler sold 97,767 shares of the business's stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $112.05, for a total transaction of $10,954,792.35. Following the transaction, the director owned 75,000 shares in the company, valued at $8,403,750. The trade was a 56.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 291,744 shares of company stock worth $32,705,007 over the last 90 days. 1.50% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On HealthEquity

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Invesco Ltd. boosted its position in HealthEquity by 50.6% during the first quarter. Invesco Ltd. now owns 2,446,198 shares of the company's stock worth $216,171,000 after acquiring an additional 821,425 shares during the last quarter. Brown Advisory Inc. boosted its position in HealthEquity by 12.0% during the fourth quarter. Brown Advisory Inc. now owns 2,086,026 shares of the company's stock worth $200,154,000 after acquiring an additional 224,016 shares during the last quarter. Westfield Capital Management Co. LP boosted its position in HealthEquity by 124.6% during the second quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company's stock worth $132,543,000 after acquiring an additional 701,819 shares during the last quarter. Northern Trust Corp boosted its position in HealthEquity by 11.7% during the fourth quarter. Northern Trust Corp now owns 1,155,043 shares of the company's stock worth $110,826,000 after acquiring an additional 121,001 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its position in HealthEquity by 1.4% during the first quarter. Goldman Sachs Group Inc. now owns 1,133,166 shares of the company's stock worth $100,138,000 after acquiring an additional 15,458 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.